Bromazolam Pallets 3mg

Description

Bromazolam Pallets

Product Description:

Bromazolam Pallets has been reported to be used for managing anxiety, promoting sleep, and reducing stimulation caused by substances such as methamphetamine.

Pharmacologically, it acts as a non‑subtype selective agonist at the benzodiazepine site of GABAA receptors, showing binding affinities of 2.81 nM at the α1 subtype, 0.69 nM at α2, and 0.62 nM at α5. Typical user reports suggest a dosage range of 1–2 mg, indicating a potency comparable to alprazolam.

Bromazolam Pallets

Bromazolam belongs to the triazolobenzodiazepine class and was first synthesized in 1976, though it was never introduced to the pharmaceutical market. In later years, it emerged as a designer drug and was first definitively identified by the EMCDDA in Sweden in 2016. Bromazolam Pallet